首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder.
【24h】

Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder.

机译:单相和双相抑郁症的经颅直流电刺激(tDCS)。

获取原文
获取原文并翻译 | 示例
       

摘要

Transcranial direct current stimulation (tDCS) is a non-invasive method for brain stimulation. Although pilot trials have shown that tDCS yields promising results for major depressive disorder (MDD), its efficacy for bipolar depressive disorder (BDD), a condition with high prevalence and poor treatment outcomes, is unknown. In a previous study we explored the effectiveness of tDCS for MDD. Here, we expanded our research, recruiting patients with MDD and BDD. We enrolled 31 hospitalized patients (24 women) aged 30-70 years 17 with MDD and 14 with BDD (n = 14). All patients received stable drug regimens for at least two weeks before enrollment and drug dosages remained unchanged throughout the study. We applied tDCS over the dorsolateral prefrontal cortex (anodal electrode on the left and cathodal on the right) using a 2 mA-current for 20 min, twice-daily, for 5 consecutive days. Depression was measured at baseline, after 5 tDCS sessions, one week later, and one month after treatment onset. We used the scales of Beck (BDI) and Hamilton-21 items (HDRS). All patients tolerated treatment well without adverse effects. After the fifth tDCS session, depressive symptoms in both study groups diminished, and the beneficial effect persisted at one week and one month. In conclusion, our preliminary study suggests that tDCS is a promising treatment for patients with MDD and BDD.2.
机译:经颅直流电刺激(tDCS)是一种用于脑部刺激的非侵入性方法。尽管初步试验表明,tDCS对重度抑郁症(MDD)产生了可喜的结果,但其对双相抑郁症(BDD)的疗效尚不明确。在先前的研究中,我们探讨了tDCS对MDD的有效性。在这里,我们扩大了研究范围,招募了患有MDD和BDD的患者。我们招募了31位30-70岁的17位MDD患者和14位BDD患者(n = 14)的住院患者(24位女性)。在入组前,所有患者均接受了至少两周的稳定药物治疗,整个研究期间药物剂量均保持不变。我们使用2 mA电流将tDCS施加于背外侧前额叶皮层(左侧为阳极,右侧为阴极),连续20天,每天两次,连续5天。在治疗5个tDCS之后,一周后和治疗开始后一个月在基线时测量抑郁。我们使用了贝克(BDI)和汉密尔顿21项目(HDRS)的量表。所有患者耐受良好,无不良反应。第五次tDCS疗程后,两个研究组的抑郁症状都减轻了,有益效果持续了一周零一个月。总之,我们的初步研究表明,tDCS对MDD和BDD患者是一种有前途的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号